Your browser doesn't support javascript.
Rapid reconstruction of SARS-CoV-2 using a synthetic genomics platform.
Thi Nhu Thao, Tran; Labroussaa, Fabien; Ebert, Nadine; V'kovski, Philip; Stalder, Hanspeter; Portmann, Jasmine; Kelly, Jenna; Steiner, Silvio; Holwerda, Melle; Kratzel, Annika; Gultom, Mitra; Schmied, Kimberly; Laloli, Laura; Hüsser, Linda; Wider, Manon; Pfaender, Stephanie; Hirt, Dagny; Cippà, Valentina; Crespo-Pomar, Silvia; Schröder, Simon; Muth, Doreen; Niemeyer, Daniela; Corman, Victor M; Müller, Marcel A; Drosten, Christian; Dijkman, Ronald; Jores, Joerg; Thiel, Volker.
  • Thi Nhu Thao T; Institute of Virology and Immunology (IVI), Bern, Switzerland.
  • Labroussaa F; Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.
  • Ebert N; Graduate School for Biomedical Science, University of Bern, Bern, Switzerland.
  • V'kovski P; Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.
  • Stalder H; Institute of Veterinary Bacteriology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.
  • Portmann J; Institute of Virology and Immunology (IVI), Bern, Switzerland.
  • Kelly J; Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.
  • Steiner S; Institute of Virology and Immunology (IVI), Bern, Switzerland.
  • Holwerda M; Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.
  • Kratzel A; Institute of Virology and Immunology (IVI), Bern, Switzerland.
  • Gultom M; Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.
  • Schmied K; Institute of Virology and Immunology (IVI), Bern, Switzerland.
  • Laloli L; Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.
  • Hüsser L; Institute of Virology and Immunology (IVI), Bern, Switzerland.
  • Wider M; Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.
  • Pfaender S; Institute of Virology and Immunology (IVI), Bern, Switzerland.
  • Hirt D; Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.
  • Cippà V; Graduate School for Biomedical Science, University of Bern, Bern, Switzerland.
  • Crespo-Pomar S; Institute of Virology and Immunology (IVI), Bern, Switzerland.
  • Schröder S; Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.
  • Muth D; Graduate School for Biomedical Science, University of Bern, Bern, Switzerland.
  • Niemeyer D; Insitute for Infectious Diseases, University of Bern, Bern, Switzerland.
  • Corman VM; Institute of Virology and Immunology (IVI), Bern, Switzerland.
  • Müller MA; Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.
  • Drosten C; Graduate School for Biomedical Science, University of Bern, Bern, Switzerland.
  • Dijkman R; Institute of Virology and Immunology (IVI), Bern, Switzerland.
  • Jores J; Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.
  • Thiel V; Graduate School for Biomedical Science, University of Bern, Bern, Switzerland.
Nature ; 582(7813): 561-565, 2020 06.
Article in English | MEDLINE | ID: covidwho-164589
ABSTRACT
Reverse genetics has been an indispensable tool to gain insights into viral pathogenesis and vaccine development. The genomes of large RNA viruses, such as those from coronaviruses, are cumbersome to clone and manipulate in Escherichia coli owing to the size and occasional instability of the genome1-3. Therefore, an alternative rapid and robust reverse-genetics platform for RNA viruses would benefit the research community. Here we show the full functionality of a yeast-based synthetic genomics platform to genetically reconstruct diverse RNA viruses, including members of the Coronaviridae, Flaviviridae and Pneumoviridae families. Viral subgenomic fragments were generated using viral isolates, cloned viral DNA, clinical samples or synthetic DNA, and these fragments were then reassembled in one step in Saccharomyces cerevisiae using transformation-associated recombination cloning to maintain the genome as a yeast artificial chromosome. T7 RNA polymerase was then used to generate infectious RNA to rescue viable virus. Using this platform, we were able to engineer and generate chemically synthesized clones of the virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)4, which has caused the recent pandemic of coronavirus disease (COVID-19), in only a week after receipt of the synthetic DNA fragments. The technical advance that we describe here facilitates rapid responses to emerging viruses as it enables the real-time generation and functional characterization of evolving RNA virus variants during an outbreak.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Genome, Viral / Cloning, Molecular / Coronavirus Infections / Genomics / Synthetic Biology / Reverse Genetics / Betacoronavirus Type of study: Observational study / Prognostic study Topics: Vaccines / Variants Limits: Animals / Humans Country/Region as subject: Asia Language: English Journal: Nature Year: 2020 Document Type: Article Affiliation country: S41586-020-2294-9

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Genome, Viral / Cloning, Molecular / Coronavirus Infections / Genomics / Synthetic Biology / Reverse Genetics / Betacoronavirus Type of study: Observational study / Prognostic study Topics: Vaccines / Variants Limits: Animals / Humans Country/Region as subject: Asia Language: English Journal: Nature Year: 2020 Document Type: Article Affiliation country: S41586-020-2294-9